172 related articles for article (PubMed ID: 6437866)
1. VIP enhances TRH-stimulated prolactin secretion of pituitary tumours. Studies with 31P NMR.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Stevens AN; Rodrigues JL; Griffiths JR
FEBS Lett; 1984 Nov; 177(1):71-5. PubMed ID: 6437866
[TBL] [Abstract][Full Text] [Related]
2. Energy metabolism in rat pituitary tumors during stimulation of prolactin by vasoactive intestinal polypeptide and thyrotropin-releasing hormone: a study with nuclear magnetic resonance spectroscopy.
Prysor-Jones RA; Silverlight JJ; Jenkins JS; Maxwell R; Griffiths JR
Endocrinology; 1986 Dec; 119(6):2574-9. PubMed ID: 3096693
[TBL] [Abstract][Full Text] [Related]
3. Autocrine and/or paracrine action of vasoactive intestinal peptide on thyrotropin-releasing hormone induced prolactin release.
Balsa JA; Cacicedo L; Lara JI; Lorenzo MJ; Pazos F; Sanchez-Franco F
Endocrinology; 1996 Jan; 137(1):144-50. PubMed ID: 8536606
[TBL] [Abstract][Full Text] [Related]
4. Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells.
Apfelbaum ME
Neuroendocrinology; 1998 Jan; 67(1):45-50. PubMed ID: 9485168
[TBL] [Abstract][Full Text] [Related]
5. Physiological roles of thyrotrophin-releasing hormone and vasoactive intestinal peptide on the pulsatile secretory patterns of prolactin in pituitary-grafted female rats.
Lafuente A; Marcó J; Esquifino AI
J Endocrinol; 1994 Sep; 142(3):581-6. PubMed ID: 7964307
[TBL] [Abstract][Full Text] [Related]
6. The mechanisms by which vasoactive intestinal peptide (VIP) and thyrotropin releasing hormone (TRH) stimulate prolactin release from pituitary cells.
Bjøro T; Sand O; Ostberg BC; Gordeladze JO; Torjesen P; Gautvik KM; Haug E
Biosci Rep; 1990 Apr; 10(2):189-99. PubMed ID: 2162702
[TBL] [Abstract][Full Text] [Related]
7. [A study on the prolactin releasing mechanism using an in vitro perfusion system with a cell column of cultured rat anterior pituitary cells].
Kageyama J
Nihon Naibunpi Gakkai Zasshi; 1984 Oct; 60(10):1243-54. PubMed ID: 6440813
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a synergistic effect of somatostatin on vasoactive intestinal polypeptide-induced prolactin release in the rat: comparison with its effect on thyrotropin (TSH)-releasing hormone-stimulated TSH release.
Michalkiewicz M; Suzuki M; Kato M
Endocrinology; 1987 Jul; 121(1):371-7. PubMed ID: 2885177
[TBL] [Abstract][Full Text] [Related]
9. Reciprocal interactions of somatostatin with thyrotropin-releasing hormone and vasoactive intestinal peptide on prolactin and growth hormone secretion in vitro.
Enjalbert A; Epelbaum J; Arancibia S; Tapia-Arancibia L; Bluet-Pajot MT; Kordon C
Endocrinology; 1982 Jul; 111(1):42-7. PubMed ID: 6123432
[TBL] [Abstract][Full Text] [Related]
10. Thyrotrophin-releasing hormone, vasoactive intestinal peptide, prolactin-releasing peptide and dopamine regulation of prolactin secretion by different lactotroph morphological subtypes in the rat.
Christian HC; Chapman LP; Morris JF
J Neuroendocrinol; 2007 Aug; 19(8):605-13. PubMed ID: 17620102
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells.
Aizawa T; Hinkle PM
Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848
[TBL] [Abstract][Full Text] [Related]
12. Effects of VIP, TRH, GABA and dopamine on prolactin release from superfused rat anterior pituitary cells.
Matsushita N; Kato Y; Shimatsu A; Katakami H; Yanaihara N; Imura H
Life Sci; 1983 Mar; 32(11):1263-9. PubMed ID: 6132313
[TBL] [Abstract][Full Text] [Related]
13. Pituitary vasoactive intestinal peptide regulates prolactin secretion in the hypothyroid rat.
Lam KS; Reichlin S
Neuroendocrinology; 1989 Nov; 50(5):524-8. PubMed ID: 2514393
[TBL] [Abstract][Full Text] [Related]
14. Plasma concentration of prolactin during four-day osmotic pump infusion of thyrotropin-releasing hormone and vasoactive intestinal polypeptide in rats.
Niimi M; Takahara J; Kawanishi K
Endocrinol Jpn; 1985 Dec; 32(6):929-32. PubMed ID: 3938733
[TBL] [Abstract][Full Text] [Related]
15. The effect of dopamine antagonists and/or VIP on TRH- or VIP-induced prolactin release in estrogen- and progesterone-treated ovariectomized rats.
Haisenleder DJ; Moy JA; Gala RR; Lawson DM
Proc Soc Exp Biol Med; 1988 Mar; 187(3):341-9. PubMed ID: 3126503
[TBL] [Abstract][Full Text] [Related]
16. Vasoactive intestinal peptide increases intracellular free calcium in rat and human pituitary tumour cells in vitro.
Prysor-Jones RA; Silverlight JJ; Jenkins JS
J Endocrinol; 1987 Jul; 114(1):119-23. PubMed ID: 3116135
[TBL] [Abstract][Full Text] [Related]
17. Pertussis toxin blocks the inhibitory effects of somatostatin on cAMP-dependent vasoactive intestinal peptide and cAMP-independent thyrotropin releasing hormone-stimulated prolactin secretion of GH3 cells.
Yajima Y; Akita Y; Saito T
J Biol Chem; 1986 Feb; 261(6):2684-9. PubMed ID: 2869031
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor stimulates the prolactin synthesis and secretion in rat pituitary cells in culture (GH4C1 cells) by increasing the intracellular concentration of free calcium.
Aanestad M; Røtnes JS; Torjesen PA; Haug E; Sand O; Bjøro T
Acta Endocrinol (Copenh); 1993 Apr; 128(4):361-6. PubMed ID: 8388615
[TBL] [Abstract][Full Text] [Related]
19. Dynamics of prolactin secretion from diethylstilbestrol-induced rat prolactinoma tissue in vitro.
Maas DL; Martinson DR; Erdmann MD; Wahle JS; Hagen TC
Proc Soc Exp Biol Med; 1995 Nov; 210(2):150-5. PubMed ID: 7568285
[TBL] [Abstract][Full Text] [Related]
20. Vasoactive intestinal peptide causes a calcium-dependent stimulation of prolactin secretion in GH4C1 cells.
Bjøro T; Haug E; Sand O; Gautvik KM
Mol Cell Endocrinol; 1984 Aug; 37(1):41-50. PubMed ID: 6432604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
